XML 52 R41.htm IDEA: XBRL DOCUMENT v3.22.0.1
Supplementary Balance Sheet Information - Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued compensation $ 1,435 $ 1,523
Preferred stock dividend 414 390
Clinical trials 1,639 1,557
Clinical trials 726 67
Director fees 141 93
Professional fees and outside services 63 38
Patent, license and other fees 43 117
Other accrued liabilities 66 66
Total accrued liabilities $ 4,527 $ 3,851